Buzzing Stocks Today, Stocks that will see action today: 29 July 2024 - UltraTech Cement, India Cements, Maruti Suzuki, Manappuram Finance, Colgate Palmolive, Cipla, Biotin, Strides Pharma, Glenmark Life, Cholamandalam Finance, Indoco Remedies, BHEL, Godawari Power, Hindustan Zinc, Jubilant Pharmova, Laxmi Organic

Stock that will see action today: July 29, 2024

Indoco Remedies consolidated net profit declines 89.26% in the June 2024 quarter

Upcoming results: Bajaj Finance, DCM Shriram, Heritage Foods, Hindustan Unilever, ICICI Prudential, ICRA, Indoco Remedies, ICICI Securities, Kajaria Ceramics, Mahindra and Mahindra Financial Services, Schaffler India, Sharda Cropchem, SRF, Steel Strips Wheels, Thyrocare Technologies, Torrent Pharmaceuticals, and United Spirits.

Stock Alert: Reliance Industries, Cyient DLM, Zensar Tech, Suzlon Energy, Federal Bank, Gensol Engineering

The company acquired a 85% stake in FPP for
$4 million to enhance its front-end marketing and distribution strength in the U.S.

Indoco Remedies - U.S. To Drive Growth: Nirmal Bang

USFDA grants approval to Indoco Remedies for generic diabetes drug, Canagliflozin and Metformin Hydrochloride tablets.

USFDA Approves Indoco Remedies’ Generic Diabetes Drug

Goa Plant II and III are under official action indicated and hence supplies moderated in Q1 FY24.

Indoco Remedies - Resolution Of Facilities A Key Monitorable: Nirmal Bang

Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 380 in its research report dated July 25, 2023.

Buy Indoco Remedies; target of Rs 380: Prabhudas Lilladher

Indoco Remedies received EU GMP certification for its Baddi manufacturing facility, allowing it to supply drug products to Europe and other regions. This certification confirms compliance with reasonable manufacturing practice requirements per the EC Directive, leading to a 0.40 per cent increase i…

Indoco Remedies shares rise following EU GMP certification

Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang.

Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang

Buzzing stocks of Go Fashion, IndiGo, Tata Motors, TVS Motor, Jupiter Wagons, Stone India, Info Edge, PFC, Cochin Shipyard, Gati, Allcargo Logistics, Karnataka Bank, TVS Motor, Indoco Remedies, Premier Explosives, Hazoor Multi Projects.

Stocks to watch on June 12, 2023

Indoco Remedies on Friday said it has received the EU GMP certification for its manufacturing site located in Himachal Pradesh. The company has received EU GMP certification from the competent health authority of Germany for its manufacturing site situated in Solan district of Himachal Pradesh.

Indoco Remedies gets EU-GMP certification for Himachal plant

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Indoco Remedies Limited is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).